nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—DRD2—nicotine dependence	0.827	1	CbGaD
Propiomazine—DRD4—brain—nicotine dependence	0.00194	0.0889	CbGeAlD
Propiomazine—Levomethadyl Acetate—CHRNB4—nicotine dependence	0.00163	0.143	CrCbGaD
Propiomazine—CHRM2—cardiovascular system—nicotine dependence	0.00161	0.0735	CbGeAlD
Propiomazine—DRD1—midbrain—nicotine dependence	0.00156	0.0712	CbGeAlD
Propiomazine—Methadyl Acetate—OPRM1—nicotine dependence	0.00147	0.13	CrCbGaD
Propiomazine—CHRM4—brain—nicotine dependence	0.00147	0.0672	CbGeAlD
Propiomazine—CHRM1—cardiovascular system—nicotine dependence	0.00146	0.0669	CbGeAlD
Propiomazine—Methadone—CHRNA10—nicotine dependence	0.00133	0.117	CrCbGaD
Propiomazine—HTR2C—midbrain—nicotine dependence	0.00121	0.0553	CbGeAlD
Propiomazine—ADRA1A—cardiovascular system—nicotine dependence	0.0012	0.0549	CbGeAlD
Propiomazine—CHRM5—brain—nicotine dependence	0.00115	0.0525	CbGeAlD
Propiomazine—Levomethadyl Acetate—CHRNA3—nicotine dependence	0.00113	0.0993	CrCbGaD
Propiomazine—ADRA1B—brain—nicotine dependence	0.00105	0.048	CbGeAlD
Propiomazine—ADRA1D—brain—nicotine dependence	0.00103	0.0469	CbGeAlD
Propiomazine—DRD1—brain—nicotine dependence	0.000979	0.0447	CbGeAlD
Propiomazine—DRD2—midbrain—nicotine dependence	0.00092	0.0421	CbGeAlD
Propiomazine—CHRM2—brain—nicotine dependence	0.000789	0.0361	CbGeAlD
Propiomazine—HTR2A—cardiovascular system—nicotine dependence	0.000777	0.0355	CbGeAlD
Propiomazine—HTR2C—brain—nicotine dependence	0.00076	0.0348	CbGeAlD
Propiomazine—CHRM1—brain—nicotine dependence	0.000718	0.0328	CbGeAlD
Propiomazine—CHRM3—brain—nicotine dependence	0.000642	0.0294	CbGeAlD
Propiomazine—Levomethadyl Acetate—OPRM1—nicotine dependence	0.000642	0.0565	CrCbGaD
Propiomazine—HTR2A—midbrain—nicotine dependence	0.000607	0.0277	CbGeAlD
Propiomazine—ADRA1A—brain—nicotine dependence	0.00059	0.027	CbGeAlD
Propiomazine—DRD2—brain—nicotine dependence	0.000578	0.0264	CbGeAlD
Propiomazine—Acetophenazine—DRD2—nicotine dependence	0.000548	0.0482	CrCbGaD
Propiomazine—HRH1—brain—nicotine dependence	0.000457	0.0209	CbGeAlD
Propiomazine—HTR2A—brain—nicotine dependence	0.000381	0.0174	CbGeAlD
Propiomazine—Methadone—OPRM1—nicotine dependence	0.000376	0.0331	CrCbGaD
Propiomazine—Triflupromazine—DRD2—nicotine dependence	0.000336	0.0296	CrCbGaD
Propiomazine—Acepromazine—DRD2—nicotine dependence	0.000311	0.0274	CrCbGaD
Propiomazine—Thioproperazine—DRD2—nicotine dependence	0.000304	0.0267	CrCbGaD
Propiomazine—Pipotiazine—DRD2—nicotine dependence	0.000299	0.0263	CrCbGaD
Propiomazine—Thiothixene—DRD2—nicotine dependence	0.000299	0.0263	CrCbGaD
Propiomazine—Mesoridazine—DRD2—nicotine dependence	0.000295	0.026	CrCbGaD
Propiomazine—Prochlorperazine—DRD2—nicotine dependence	0.000286	0.0251	CrCbGaD
Propiomazine—Fluphenazine—DRD2—nicotine dependence	0.000259	0.0227	CrCbGaD
Propiomazine—Chlorprothixene—DRD2—nicotine dependence	0.000235	0.0207	CrCbGaD
Propiomazine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000231	0.00165	CbGpPWpGaD
Propiomazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000227	0.00163	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—FGD1—nicotine dependence	0.000224	0.0016	CbGpPWpGaD
Propiomazine—DRD4—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000223	0.00159	CbGpPWpGaD
Propiomazine—Thioridazine—DRD2—nicotine dependence	0.000223	0.0196	CrCbGaD
Propiomazine—DRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000222	0.00159	CbGpPWpGaD
Propiomazine—CHRM5—GPCR ligand binding—OPRM1—nicotine dependence	0.000222	0.00159	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—FGD1—nicotine dependence	0.000221	0.00158	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.00022	0.00157	CbGpPWpGaD
Propiomazine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00022	0.00157	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—FGD1—nicotine dependence	0.000219	0.00157	CbGpPWpGaD
Propiomazine—Trimipramine—DRD2—nicotine dependence	0.000218	0.0191	CrCbGaD
Propiomazine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000214	0.00153	CbGpPWpGaD
Propiomazine—Methotrimeprazine—DRD2—nicotine dependence	0.000213	0.0187	CrCbGaD
Propiomazine—CHRM5—Signaling by GPCR—FGD1—nicotine dependence	0.000212	0.00152	CbGpPWpGaD
Propiomazine—DRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000211	0.00151	CbGpPWpGaD
Propiomazine—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.000211	0.00151	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000211	0.00151	CbGpPWpGaD
Propiomazine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000211	0.00151	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000211	0.00151	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00021	0.0015	CbGpPWpGaD
Propiomazine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00021	0.0015	CbGpPWpGaD
Propiomazine—Promethazine—DRD2—nicotine dependence	0.000209	0.0184	CrCbGaD
Propiomazine—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000209	0.0015	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000209	0.00149	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.000209	0.00149	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000207	0.00148	CbGpPWpGaD
Propiomazine—Trifluoperazine—DRD2—nicotine dependence	0.000207	0.0182	CrCbGaD
Propiomazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000206	0.00147	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000206	0.00147	CbGpPWpGaD
Propiomazine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000206	0.00147	CbGpPWpGaD
Propiomazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000205	0.00147	CbGpPWpGaD
Propiomazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000205	0.00146	CbGpPWpGaD
Propiomazine—Perphenazine—DRD2—nicotine dependence	0.000204	0.018	CrCbGaD
Propiomazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000203	0.00145	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000202	0.00144	CbGpPWpGaD
Propiomazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000202	0.00144	CbGpPWpGaD
Propiomazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000201	0.00144	CbGpPWpGaD
Propiomazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0002	0.00143	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.000199	0.00142	CbGpPWpGaD
Propiomazine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000198	0.00142	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000194	0.00139	CbGpPWpGaD
Propiomazine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000192	0.00137	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000191	0.00137	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000191	0.00136	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.00019	0.00136	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00019	0.00136	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00019	0.00136	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000188	0.00134	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000187	0.00134	CbGpPWpGaD
Propiomazine—Promazine—DRD2—nicotine dependence	0.000184	0.0162	CrCbGaD
Propiomazine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000184	0.00132	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000182	0.0013	CbGpPWpGaD
Propiomazine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000181	0.00129	CbGpPWpGaD
Propiomazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000174	0.00124	CbGpPWpGaD
Propiomazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000174	0.00124	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000173	0.00124	CbGpPWpGaD
Propiomazine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000173	0.00124	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000173	0.00124	CbGpPWpGaD
Propiomazine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000173	0.00123	CbGpPWpGaD
Propiomazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000172	0.00123	CbGpPWpGaD
Propiomazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000171	0.00122	CbGpPWpGaD
Propiomazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00017	0.00122	CbGpPWpGaD
Propiomazine—DRD4—GPCR ligand binding—DRD2—nicotine dependence	0.00017	0.00121	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—TAS2R16—nicotine dependence	0.000169	0.00121	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000168	0.0012	CbGpPWpGaD
Propiomazine—CHRM4—GPCR ligand binding—DRD2—nicotine dependence	0.000168	0.0012	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—TAS2R16—nicotine dependence	0.000167	0.00119	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000165	0.00118	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000165	0.00118	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.000165	0.00118	CbGpPWpGaD
Propiomazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000164	0.00118	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000164	0.00117	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.000164	0.00117	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000162	0.00116	CbGpPWpGaD
Propiomazine—Chlorpromazine—DRD2—nicotine dependence	0.000162	0.0143	CrCbGaD
Propiomazine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000162	0.00116	CbGpPWpGaD
Propiomazine—CHRM5—GPCR ligand binding—DRD2—nicotine dependence	0.00016	0.00115	CbGpPWpGaD
Propiomazine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.00016	0.00114	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—TAS2R16—nicotine dependence	0.00016	0.00114	CbGpPWpGaD
Propiomazine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000157	0.00112	CbGpPWpGaD
Propiomazine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000157	0.00112	CbGpPWpGaD
Propiomazine—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000156	0.00112	CbGpPWpGaD
Propiomazine—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.000156	0.00111	CbGpPWpGaD
Propiomazine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000154	0.0011	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000154	0.0011	CbGpPWpGaD
Propiomazine—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000153	0.00109	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000153	0.00109	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000152	0.00109	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.000151	0.00108	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.00015	0.00107	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.00015	0.00107	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.00015	0.00107	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000149	0.00107	CbGpPWpGaD
Propiomazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000149	0.00107	CbGpPWpGaD
Propiomazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000149	0.00106	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.000149	0.00106	CbGpPWpGaD
Propiomazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000148	0.00106	CbGpPWpGaD
Propiomazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000148	0.00106	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000147	0.00105	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000147	0.00105	CbGpPWpGaD
Propiomazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000146	0.00105	CbGpPWpGaD
Propiomazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000146	0.00104	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—OPRM1—nicotine dependence	0.000133	0.000949	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—FGD1—nicotine dependence	0.000133	0.000948	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—OPRM1—nicotine dependence	0.000131	0.000936	CbGpPWpGaD
Propiomazine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.000131	0.000935	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—FGD1—nicotine dependence	0.000131	0.000935	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.00013	0.00093	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—OPRM1—nicotine dependence	0.000125	0.000897	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—FGD1—nicotine dependence	0.000125	0.000895	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.000125	0.000895	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000125	0.00089	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—OPRM1—nicotine dependence	0.000121	0.000862	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000119	0.000854	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—FGD1—nicotine dependence	0.000119	0.000853	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—OPRM1—nicotine dependence	0.000119	0.00085	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000118	0.000843	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	0.000118	0.000842	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—AKR1B10—nicotine dependence	0.000117	0.000837	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—AKR1B10—nicotine dependence	0.000116	0.000826	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.000115	0.000821	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—OPRM1—nicotine dependence	0.000114	0.000814	CbGpPWpGaD
Propiomazine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000114	0.000812	CbGpPWpGaD
Propiomazine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	0.000113	0.00081	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000113	0.000808	CbGpPWpGaD
Propiomazine—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000113	0.000808	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	0.000113	0.000806	CbGpPWpGaD
Propiomazine—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.000113	0.000805	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000112	0.000803	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.000112	0.000801	CbGpPWpGaD
Propiomazine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000112	0.000797	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000111	0.000795	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000111	0.000793	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—AKR1B10—nicotine dependence	0.000111	0.000791	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000111	0.000791	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	0.000109	0.000776	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000107	0.000765	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	0.000105	0.000754	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000104	0.000743	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000102	0.000731	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	0.000102	0.00073	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	9.79e-05	0.0007	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	9.77e-05	0.000699	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—DRD2—nicotine dependence	9.6e-05	0.000686	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—DRD2—nicotine dependence	9.47e-05	0.000677	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	9.28e-05	0.000664	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—DRD2—nicotine dependence	9.07e-05	0.000648	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	9.02e-05	0.000645	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	9.02e-05	0.000645	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—FGD1—nicotine dependence	9.01e-05	0.000644	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	8.89e-05	0.000635	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	8.88e-05	0.000635	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	8.86e-05	0.000634	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	8.86e-05	0.000633	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—FGD1—nicotine dependence	8.85e-05	0.000632	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	8.83e-05	0.000631	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—FGD1—nicotine dependence	8.82e-05	0.00063	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	8.8e-05	0.000629	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—FGD1—nicotine dependence	8.79e-05	0.000628	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	8.72e-05	0.000623	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—DRD2—nicotine dependence	8.71e-05	0.000623	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	8.7e-05	0.000622	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	8.69e-05	0.000621	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	8.68e-05	0.000621	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	8.64e-05	0.000618	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	8.63e-05	0.000617	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—CYP2A7—nicotine dependence	8.63e-05	0.000617	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—DRD2—nicotine dependence	8.6e-05	0.000615	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	8.52e-05	0.000609	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—WASF2—nicotine dependence	8.25e-05	0.00059	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—DRD2—nicotine dependence	8.23e-05	0.000589	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	8.19e-05	0.000586	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—WASF2—nicotine dependence	8.14e-05	0.000582	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	8.06e-05	0.000576	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	8.04e-05	0.000575	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	8.02e-05	0.000573	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	7.99e-05	0.000571	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	7.96e-05	0.000569	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	7.91e-05	0.000566	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—WASF1—nicotine dependence	7.91e-05	0.000565	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	7.89e-05	0.000564	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—DRD2—nicotine dependence	7.85e-05	0.000561	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	7.83e-05	0.00056	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	7.81e-05	0.000559	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—WASF1—nicotine dependence	7.8e-05	0.000558	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—WASF2—nicotine dependence	7.79e-05	0.000557	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	7.79e-05	0.000557	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	7.76e-05	0.000555	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	7.74e-05	0.000553	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	7.69e-05	0.00055	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	7.67e-05	0.000548	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—WASF1—nicotine dependence	7.47e-05	0.000534	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—WASF2—nicotine dependence	7.43e-05	0.000531	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	7.39e-05	0.000528	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	7.33e-05	0.000524	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—OPRM1—nicotine dependence	7.12e-05	0.000509	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—WASF1—nicotine dependence	7.12e-05	0.000509	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	7.07e-05	0.000506	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	7.02e-05	0.000502	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—OPRM1—nicotine dependence	7.02e-05	0.000502	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—OPRM1—nicotine dependence	6.73e-05	0.000481	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	6.71e-05	0.00048	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	6.42e-05	0.000459	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	6.42e-05	0.000459	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—OPRM1—nicotine dependence	6.41e-05	0.000458	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	6.4e-05	0.000458	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	6.38e-05	0.000456	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	6.36e-05	0.000455	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	6.35e-05	0.000454	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	6.32e-05	0.000452	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	6.3e-05	0.00045	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	6.28e-05	0.000449	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	6.09e-05	0.000435	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	6.08e-05	0.000435	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	5.83e-05	0.000417	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	5.83e-05	0.000417	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	5.82e-05	0.000416	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	5.8e-05	0.000414	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	5.78e-05	0.000413	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	5.72e-05	0.000409	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	5.71e-05	0.000408	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—WASF2—nicotine dependence	5.61e-05	0.000401	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	5.52e-05	0.000394	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—WASF2—nicotine dependence	5.5e-05	0.000394	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—WASF2—nicotine dependence	5.49e-05	0.000392	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	5.48e-05	0.000392	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—WASF2—nicotine dependence	5.47e-05	0.000391	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	5.42e-05	0.000387	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	5.4e-05	0.000386	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—WASF1—nicotine dependence	5.38e-05	0.000384	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	5.29e-05	0.000378	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—WASF1—nicotine dependence	5.28e-05	0.000377	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—WASF1—nicotine dependence	5.26e-05	0.000376	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	5.25e-05	0.000375	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—WASF1—nicotine dependence	5.24e-05	0.000375	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	5.19e-05	0.000371	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	5.18e-05	0.00037	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—DRD2—nicotine dependence	5.15e-05	0.000368	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—DRD2—nicotine dependence	5.08e-05	0.000363	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—DRD2—nicotine dependence	4.86e-05	0.000348	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	4.84e-05	0.000346	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	4.76e-05	0.00034	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	4.75e-05	0.00034	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	4.74e-05	0.000339	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	4.72e-05	0.000338	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	4.68e-05	0.000334	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	4.66e-05	0.000333	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—DRD2—nicotine dependence	4.63e-05	0.000331	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	4.57e-05	0.000327	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	3.96e-05	0.000283	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	3.8e-05	0.000271	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	3.44e-05	0.000246	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DRD2—nicotine dependence	3.44e-05	0.000246	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DRD2—nicotine dependence	3.42e-05	0.000245	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DRD2—nicotine dependence	3.41e-05	0.000244	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	3.38e-05	0.000242	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	3.37e-05	0.000241	CbGpPWpGaD
